Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases

Influenza Clinical Trials


A listing of Influenza medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Birmingham : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Birmingham : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Birmingham : The University of Alabama at Birmingham Updated

Patients are needed to participate in a clinical research study for the treatment of Influenza, Human

Birmingham : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Birmingham : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Dothan : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Huntsville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Mobile : Coastal Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Scottsboro : Scottsboro Quick Care Clinic

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Arizona

Camp Verde : Clinical Trial Connection

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Camp Verde : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Chandler : Warner Family Practice

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mesa : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Phoenix : Precision Trials LLC

A Phase 1/Phase 2 clinical study for patients with Influenza

Tempe : Clinical Research Consortium Arizona

A clinical trial seeking patients for an Influenza treatment research study

Tucson : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Tucson : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Arkansas

Harrisburg : Clinical Research Connections, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Hot Springs : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Jonesboro : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Jonesboro : NEA Baptist Clinic

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Little Rock : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Little Rock : Baptist Health Center for Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Little Rock : Arkansas Children's Hospital

A Phase 1/Phase 2 clinical study for patients with Influenza

Little Rock : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

California

San Gabriel : California Center for Clinical Research

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza

Anaheim : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Anaheim : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Anaheim : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Bellflower : SoCal Clinical Research Med Group

A Phase 1/Phase 2 clinical study for patients with Influenza

Beverly Hills : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Burbank : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Canoga Park : Sherif Khamis MD Inc

A Phase 1/Phase 2 clinical study for patients with Influenza

Carmichael : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Chula Vista : eStudySite

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Chula Vista : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chula Vista : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Cypress : WCCT

A clinical research study of One or two doses of replication incompetent adenovirus given in a tablet and Placebo Tablet for the treatment of Season Influenza

Daly City : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Fountain Valley : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Fresno : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Fresno : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Fresno : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Gold River : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Harbor City : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Harbor City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Huntington Beach : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Huntington Beach : Beach Physicians Medical Group, Inc.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

La Mesa : eStudySite

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

La Mesa : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

La Mesa : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

La Puente : 238, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lakewood : Advanced Medical Research

A Phase 1/Phase 2 clinical study for patients with Influenza

Lomita : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Long Beach : Novo Research, Inc.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Los Angeles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Los Angeles : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Madera : Madera Family Medical Group

A Phase 1/Phase 2 clinical study for patients with Influenza

Modesto : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Norwalk : Lucita M. Cruz, MD, Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Oakland : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Oceanside : eStudySite

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Oceanside : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Ontario : 411, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Orange : Clinical Trials of Orange County, Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Paramount : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Paramount : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Pleasanton : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Redding : Northern California Clinical Research Center

A clinical trial seeking patients for an Influenza treatment research study

Sacramento : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Sacramento : Benchmark Research - Sacramento

A clinical trial seeking patients for an Influenza treatment research study

Sacramento : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

San Diego : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

San Diego : California Research Foundation

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Diego : San Diego Sports Medicine & Family Health Center

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Diego : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Diego : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Francisco : Benchmark Research - San Francisco

A clinical trial seeking patients for an Influenza treatment research study

San Gabriel : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Santa Clara : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Stockton : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Tustin : Orange County Research Center, Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Upland : SC Clinical Research, Inc.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Upland : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Walnut Creek : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Colorado

Aurora : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Aurora : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Centennial : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Colorado Springs : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Colorado Springs : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Colorado Springs : Lynn Institute of the Rockies

A clinical trial seeking patients for an Influenza treatment research study

Colorado Springs : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Colorado Springs : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Denver : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Northglenn : Complete Family Care

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Thornton : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Connecticut

Hartford : Connecticut Children's Medical Center

A Phase 1/Phase 2 clinical study for patients with Influenza

Milford : Clinical Research Consulting

A clinical trial seeking patients for an Influenza treatment research study

Stamford : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Waterbury : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

District of Columbia

Washington : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Florida

Tampa : University of South Florida - Tampa General Hospital

A double-blind, randomized, stratified, multi-center trial evaluating conventional and high dose oseltamivir in the treatment of immunocompromised patients with influenza

Boca Raton : BRCR Medical Center, Inc DBA Boca Raton Clinical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Boynton Beach : Zasa Clinical Research, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Celebration : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Chiefland : Southeast Clinical Research, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Clearwater : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Coral Gables : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Coral Gables : Clinical Research of South Florida

A clinical trial seeking patients for an Influenza treatment research study

Coral Gables : Sanitas Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Coral Gables : Clinical Research of South Florida

Patients are needed to participate in a clinical research study evaluating Bifidobacterium lactis HN019 and Placebo for the treatment of Influenza

DeLand : Avail Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Edgewater : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Edgewater : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Hialeah : A.G.A Clinical Trials

A Phase 1/Phase 2 clinical study for patients with Influenza

Hialeah : 416, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Hialeah : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Hialeah : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Hollywood : Broward Research Group

A clinical trial seeking patients for a Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections treatment research study

Jacksonville : Jacksonville Center for Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Jacksonville : Westside Center for Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Jacksonville : Southeast Clinical Research, LLC - Parent

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Jacksonville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Kissimmee : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Kissimmee : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lake Mary : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Lauderdale Lakes : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Lauderdale Lakes : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miami : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Miami : Miami Research Associates

A clinical trial seeking patients for a Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections treatment research study

Miami : Columbus Clinical Services, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Miami : New Horizon Research Center, Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Miami : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miami : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miami : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miami : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miami Lakes : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Miami Lakes : Crystal Biomedical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Orlando : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Orlando : DCT - FMC, LLC, d/b/a Discovery Clinical Trials

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Ormond Beach : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Port Orange : Progressive Medical Research

A clinical trial seeking patients for an Influenza treatment research study

Port Orange : Advanced Medical Research Center

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Port Orange : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

South Miami : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

St. Cloud : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

St. Cloud : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Tamarac : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tampa : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Tampa : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tampa : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

West Palm Beach : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Georgia

Columbus : Columbus Regional Research Institute

FLU Got You Blue? Ask NOW about a clinical research study that you may qualify for.

Columbus : Columbus Regional Research Institute

What do you do when you have the flu?

Atlanta : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Atlanta : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Atlanta : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Canton : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Columbus : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Dunwoody : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Norcross : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Oakwood : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Riverdale : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Savannah : Meridian Research

A clinical trial seeking patients for an Influenza treatment research study

Snellville : Dr. B. Abraham, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Snellville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Idaho

Blackfoot : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Idaho Falls : Women's Healthcare Associates P.A.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Idaho Falls : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Meridian : ACR - Boise

A clinical trial seeking patients for an Influenza treatment research study

Nampa : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Twin Falls : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Illinois

Chicago :

A Phase 4 clinical study for patients with Influenza

Dekalb : 299, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Peoria : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Indiana

Brownsburg : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Evansville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Indianapolis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Lafayette : Lafayette Clinical Research Group

A Phase 1/Phase 2 clinical study for patients with Influenza

Iowa

Council Bluffs : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Iowa City : University of Iowa Hospitals and Clinics

A Phase 1/Phase 2 clinical study for patients with Influenza

Kansas

Augusta : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Newton : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Wichita : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Wichita : Heartland Research Associates, LLC

A clinical trial seeking patients for an Influenza treatment research study

Wichita : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Wichita : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Kentucky

Bardstown : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lexington : Central Kentucky Research Associates

A clinical trial seeking patients for an Influenza treatment research study

Louisville : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Madisonville : Baptist Health Clinical Studies

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Louisiana

Bossier City : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Eunice : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Haughton : 265, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lake Charles : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Mandeville : Clinical Trials Management, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mangham : 408, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Metairie : Benchmarch Research - New Orleans

A clinical trial seeking patients for an Influenza treatment research study

Metairie : Medipharmics, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Metairie : Clinical Trials Management, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Metairie :

A clinical trial to evaluate treatments using Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and non-adjuvanted Quadrivalent Influenza Vaccine (QIV) for patients with Influenza

Monroe : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Natchitoches : KAMP Medical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

New Orleans : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Opelousas : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Shreveport : Louisiana State University Health Sciences Center

A Phase 1/Phase 2 clinical study for patients with Influenza

Maine

Bangor : Paul Shapero, MD

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Maryland

Baltimore : SNBL Clinical Pharmacology Center

A clinical trial to evaluate treatments using FGI-101-1A6 for patients with Influenza

Baltimore : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bethesda : Bethesda Allergy, Asthma & Research Center, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Columbia : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Columbia : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Towson : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Massachusetts

Boston : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Fall River : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Fall River : Neccr Imca, Llc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Methuen : ActivMed Practices & Research

A clinical trial seeking patients for an Influenza treatment research study

Springfield : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Walburn : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Watertown : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Worcester : University of Massachusetts Medical Center

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Worcester : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Michigan

Detroit : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madison Heights : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Rochester : Remedica, LLC

Patients are needed to participate in a clinical research study evaluating Bifidobacterium lactis HN019 and Placebo for the treatment of Influenza

Royal Oak : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Troy : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Troy : Oakland Medical Research Center

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Troy : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Troy : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Minnesota

Minneapolis : DaVita Clinical Research

A clinical research study of VIS410 and Placebo for the treatment of Influenza

St. Paul : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Mississippi

Carriere : Dr Haidar's Clinic

A Phase 1/Phase 2 clinical study for patients with Influenza

Olive Branch : Olive Branch Family Medical Center

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Missouri

Bridgeton : DePaul Health Center

A Phase 1/Phase 2 clinical study for patients with Influenza

Kansas City : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Kansas City : Center for Pharmaceutical Research

A clinical trial seeking patients for an Influenza treatment research study

St. Louis : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

St. Louis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

St. Louis : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Montana

Billings : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Butte : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Missoula : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Nebraska

Bellevue : Meridian Research

A clinical trial seeking patients for an Influenza treatment research study

Bellevue : Pioneer Clinical Research, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Bellevue : The Asthma & Allergy Center, P.C. master

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Bellevue :

A clinical trial to evaluate treatments using Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and non-adjuvanted Quadrivalent Influenza Vaccine (QIV) for patients with Influenza

Bellevue : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Fremont : Beacom Family Health Connection

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Lincoln : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Lincoln : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Lincoln : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Norfolk : Meridian Research

A clinical trial seeking patients for an Influenza treatment research study

Omaha : Meridian Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Omaha : 402, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Nevada

Las Vegas : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Las Vegas : Clinical Research Consortium-Nevada

A clinical trial seeking patients for an Influenza treatment research study

Las Vegas : eStudySite

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Las Vegas : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Las Vegas : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Las Vegas : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Las Vegas : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Las Vegas : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

New Hampshire

Newington : ActivMed Practices & Research

A clinical trial seeking patients for an Influenza treatment research study

New Jersey

Berlin : Comprehensive Clinical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Teaneck : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

New Mexico

Albuquerque : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

New York

Endwell : Regional Clinical Research, Inc.

A clinical trial seeking patients for an Influenza treatment research study

New York : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Rochester : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Rochester : Rochester Clinical Research

A clinical trial seeking patients for an Influenza treatment research study

Rochester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Syracuse : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Syracuse : 264, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Syracuse : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

North Carolina

Cary : PMG Research of Cary

Pediatric flu vaccine research study.

Charlotte : PMG Research of Charlotte

Flu Vaccine – Ages 18-49

Raleigh : PMG Research of Raleigh

Flu Vaccine – Ages 18-49

Raleigh : PMG Research of Raleigh

Flu Vaccine – For Children

Raleigh : Wake Research Associates New

Flu Vaccine for Ages 50+

Winston-Salem : PMG Research of Winston-Salem

Flu Vaccine – For Children

Asheville : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Boone : Blue Ridge Pediatric and Adolescent Medicine Group

A Phase 1/Phase 2 clinical study for patients with Influenza

Calabash : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Chapel Hill : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chapel Hill : University of North Carolina

Patients are needed to participate in a clinical research study of FluMist to evaluate Influenza

Charlotte : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Charlotte : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Charlotte : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Clyde : 403, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Greensboro : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Hickory : PMG Research of Hickory, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Hickory : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Huntersville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lexington : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Matthews : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Morganton : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Raleigh : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Raleigh : Wake Research

A clinical trial seeking patients for an Influenza treatment research study

Winston-Salem : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Winston-Salem : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

North Dakota

Bismarck : St. Alexius Medical Center

A research study for patients who have been diagnosed with influenza.

Ohio

Beavercreek : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Cincinnati : Sentral Clinical Research Services, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Cleveland : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Cleveland : Rapid Medical Research, Inc.

A clinical trial seeking patients for an Influenza treatment research study

Columbus : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Columbus : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Dayton : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Dayton : 281, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Kettering : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lyndhurst : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Milford : Hometown Urgent Care & Occupational Health

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Sylvania : ProMedica Health System, Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Toledo : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Toledo : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Toledo : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Toledo : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Wadsworth : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Oklahoma

Norman : Lynn Institute of Norman

A clinical trial seeking patients for an Influenza treatment research study

Oklahoma City : Lynn Health Science Institute

A clinical trial seeking patients for an Influenza treatment research study

Oklahoma City : Dr Santiago Reyes

A Phase 1/Phase 2 clinical study for patients with Influenza

Tulsa : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Tulsa : Vital Prospects Clinical Research Institute, P.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Oregon

Gresham : Cyn3rgy Research

A Phase 1/Phase 2 clinical study for patients with Influenza

Pennsylvania

Belle Vernon : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Erie : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Hermitage : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Indiana : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lansdale : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Lansdale : Detweiler Family Medicine & Associates

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Philadelphia : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Philadelphia : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Philadelphia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pittsburgh : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Pittsburgh : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Pittsburgh : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pittsburgh : University of Pittsburgh, Division of Geriatric Medicine

Patients are needed to participate in a clinical research study of High Dose Inactivated Influenza Vaccine and Standard Dose Inactivated Influenza Vaccine to evaluate Influenza

Scottdale : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Scottdale : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sellersville : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Smithfield : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Uniontown : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Warminster : Warminster Medical Associates, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Rhode Island

Cumberland : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Warwick : AAPRI Clinical Research Institute

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Warwick : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

South Carolina

Mt. Pleasant : PMG Research of Charleston

Flu Vaccine – For Children

Charleston : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Cheraw : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Greenville : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Greer : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

North Myrtle Beach : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Rock Hill : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Simpsonville : Hillcrest Clinical Research, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Spartanburg : Spartanburg Medical Research

Patients are needed to participate in a clinical research study evaluating Flufirvitide 3 and Placebo for Flufirvitide-3 for the treatment of Influenza

South Dakota

Dakota Dunes : Meridian Research

A clinical trial seeking patients for an Influenza treatment research study

Rapid City : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Rapid City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sioux Falls : Sanford Research University of South Dakota

A Phase 1/Phase 2 clinical study for patients with Influenza

Tennessee

Nashville : Clinical Research Associates, Inc.

Upper Respiratory Symptoms Research Study

Columbia : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Columbia : Clinical Research Solutions, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Franklin : HCCA Clinical Research Solutions

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Franklin : Clinical Research Solutions, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Franklin : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Jackson : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Jackson : HCCA Clinical Research Solutions

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Jackson : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Kingsport : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Knoxville : PMG Research of Knoxville

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Memphis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Memphis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Nashville : Clinical Research Associates

A clinical trial seeking patients for an Influenza treatment research study

Nashville : Clinical Research Solutions, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Smyrna : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Smyrna : Clinical Research Solutions, PC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Smyrna : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Texas

San Antonio : Sun Research Institute

Are you suffering from Flu-like symptoms?

San Antonio : Endeavor Clinical Trials, PA

Do you have symptoms of the flu?

Allen : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Austin : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Austin : Benchmark Reseach

A clinical trial seeking patients for an Influenza treatment research study

Austin :

A clinical trial to evaluate treatments using Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and non-adjuvanted Quadrivalent Influenza Vaccine (QIV) for patients with Influenza

Beaumont : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Bryan : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Corpus Christi : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Fort Worth : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Fort Worth : Benchmark Research - Fort Worth

A clinical trial seeking patients for an Influenza treatment research study

Fort Worth :

A clinical trial to evaluate treatments using Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and non-adjuvanted Quadrivalent Influenza Vaccine (QIV) for patients with Influenza

Houston : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Houston : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Houston : West Houston Clinical Research Service

A Phase 1/Phase 2 clinical study for patients with Influenza

Houston : Avant Research Assoc.

A Phase 1/Phase 2 clinical study for patients with Influenza

Houston : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Houston : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Houston : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Houston : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Houston : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Irving : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Lake Jackson : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

North Richland Hills : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Pharr : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Plano : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Plano : ACRC Trials

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Plano : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Plano : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Angelo : Benchmark Research - San Angelo

A clinical trial seeking patients for an Influenza treatment research study

San Antonio : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

San Antonio : DCT-Stone Oak, LLC dba Discovery Clinical Trials

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Antonio : Oakwell Clinical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Antonio : DBA Southwest Clinic

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Antonio : Sun Research Institute, LLC

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

San Antonio : 400, Novartis investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

San Antonio : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sealy : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sugar Land : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Sugar Land : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Tomball : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Victoria : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Waco : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Utah

Clinton : Westside Medical

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Draper : Focus Clinical Research

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Layton : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Orem : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Payson : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Provo : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Salt Lake City : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Salt Lake City : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Salt Lake City : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Salt Lake City : Jean Brown Research

A clinical trial seeking patients for an Influenza treatment research study

Salt Lake City : J. Lewis Research - FirstMed East

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Salt Lake City : Foothill Family Clinic

A Phase 1/Phase 2 clinical study for patients with Influenza

Salt Lake City : Foothill Family Clinic South

A Phase 1/Phase 2 clinical study for patients with Influenza

Salt Lake City : First Med

A Phase 1/Phase 2 clinical study for patients with Influenza

Salt Lake City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

South Jordan : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

South Jordan : Copperview Medical Center

A Phase 1/Phase 2 clinical study for patients with Influenza

South Jordan : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

St. George : Dixie Pediatrics

A Phase 1/Phase 2 clinical study for patients with Influenza

Virginia

Newport News : Health Research of Hampton Roads, Inc.

Influenza (Flu) Research – Adults

Charlottesville : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Charlottesville : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Midlothian : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Newport News : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Norfolk : Clinical Research Associates of Tidewater

A clinical trial seeking patients for an Influenza treatment research study

Roanoke : Carilion Infectious Disease

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Roanoke : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Washington

Ellensburg : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Port Orchard : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Seattle : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Spokane : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Spokane : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Spokane : Rockwood Clinic

A Phase 1/Phase 2 clinical study for patients with Influenza

Spokane : Rockwood North Clinic

A Phase 1/Phase 2 clinical study for patients with Influenza

Wisconsin

La Crosse : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Marshfield : GSK Investigational Site

A clinical research study of FluLaval Quadrivalent and Fluzone Quadrivalent for the treatment of Influenza

Milwaukee : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Argentina

Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Buenos Aires : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Buenos Aires : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Buenos Aires : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Ciudad Autonoma Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ciudad Autonoma Buenos Aires : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Cordoba : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Córdoba : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

La Palta : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

La Plata : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mar del Plata : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Ramos Mejia : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Miguel De Tucuman : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Santa Fe : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Vicente Lopez : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Australia

Adelaide : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Bedford Park : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Darlinghurst : 103, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Darlinghurst : 102, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Heidelberg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Melbourne : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Merewether : 101, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Westmead :

A Phase 4 clinical study for patients with Influenza

Belgium

Brussel : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Brussel : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Bruxelles : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Bruxelles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bruxelles : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bruxelles : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Chenée :

A clinical trial seeking patients for a research study for the treatment of Influenza

Gozee :

A clinical trial seeking patients for a research study for the treatment of Influenza

Ham :

A clinical trial seeking patients for a research study for the treatment of Influenza

Leuven : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Leuven : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Linkebeek :

A clinical trial seeking patients for a research study for the treatment of Influenza

Mont-sur-Marchienne :

A clinical trial seeking patients for a research study for the treatment of Influenza

Brazil

Rio de Janeiro : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Rio de Janeiro : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Sao Paulo : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Sao Paulo : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

São Paulo : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Bulgaria

Burgas :

A clinical trial seeking patients for a research study for the treatment of Influenza

Burgas :

A clinical trial seeking patients for a research study for the treatment of Influenza

Haskovo :

A clinical trial seeking patients for a research study for the treatment of Influenza

Plovdiv : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Samokov :

A clinical trial seeking patients for a research study for the treatment of Influenza

Sevlievo :

A clinical trial seeking patients for a research study for the treatment of Influenza

Sliven :

A clinical trial seeking patients for a research study for the treatment of Influenza

Sofia :

A clinical trial seeking patients for a research study for the treatment of Influenza

Sofia :

A clinical trial seeking patients for a research study for the treatment of Influenza

Sofia :

A clinical trial seeking patients for a research study for the treatment of Influenza

Varna :

A clinical trial seeking patients for a research study for the treatment of Influenza

Varna :

A clinical trial seeking patients for a research study for the treatment of Influenza

Canada

Brampton : Aggarwal and Associates Ltd

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Burlington : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Cambridge : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Corunna : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Edmonton : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Etobicoke : Dr. Anil K. Gupta Medicine Professional Corporation

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Halifax : QEII Health Science Centre

A clinical study for patients with Influenza

Hamilton : McMaster

A clinical study for patients with Influenza

Hamilton : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hamilton : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Langley : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

London : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Mirabel : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Mirabel : Omnispec Clinical Research Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Montreal : MUCH

A clinical study for patients with Influenza

Montreal : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Montreal : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Newmarket : SKDS Research Inc.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Newmarket : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Niagara Falls : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Oshawa : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Ottawa : Ottawa General

A clinical study for patients with Influenza

Ottawa : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Pierrefonds : MUHC-Vaccine Study Centre

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Quebec : CHUl/CHUQ

A clinical study for patients with Influenza

Quebec : Clinique Medicale St-Louis (Recherche) Inc

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Québec : inVentiv Health Clinique

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Québec : Centre de recherche-CHU de Québec

A Phase 2 clinical study for patients with Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases or Respiratory Tract Infections

Saint John : Saint John Regional Hospital

A clinical study for patients with Influenza

Sainte Foy : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sarnia : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Saskatoon : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Scarborough : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Sherbrooke : CHUS

A clinical study for patients with Influenza

Sherbrooke : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Surrey : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Surrey : Fraser Health Authority

A clinical trial to evaluate treatments for patients with Influenza

Toronto : Mount Sinai

A clinical study for patients with Influenza

Toronto : Influence Study Site Updated

A clinical research study of Nitazoxanide and Oseltamivir for the treatment of Influenza

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Toronto : 182,Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Toronto : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Toronto : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Trois-Rivières : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Vancouver : Vancouver General

A clinical study for patients with Influenza

Vancouver : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Vancouver : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Victoria : New

A Phase 2 clinical study for patients with Influenza

Chile

Santiago : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Viña del Mar Valparaiso : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

China

Beijing : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chengdu : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chongqing : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guangzhou : Guangzhou Institute of Respiratory Disease

A clinical trial seeking patients for a research study for the treatment of Influenza

Guangzhou : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hangzhou : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nanchang : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Colombia

Barranquilla : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bogota : Centro de Investigacion Clinica - CAFAM

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Bogota : Clinica Colsanitas S.A. sede Clinica Universitaria Columbia

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Bogota : Administradora Country S.A.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Bogota : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bogotá : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Cali : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Cali : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Cali : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Floridablanca : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Medellin : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Medellín : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Czech Republic

Brno : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Brno - Bohunice : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Chlumec nad Cidlinou : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Decin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Jindrichuv Hradec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Liberec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Lipnik nad Becvou : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Nachod : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Odolena voda : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Ostrava - Poruba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Pardubice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Praha 5 : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Praha 6 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Zlin : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Denmark

Odense C : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Dominican Republic

Santo Domingo : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Santo Domingo : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Santo Domingo : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

El Salvador

San Salvador : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Santa Tecla : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Estonia

Tallinn : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tallinn : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tartu : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Finland

Kokkola : 005, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Seinäjoki : 008, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

France

Aix en Provence : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Angers : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza

Bron :

A Phase 4 clinical study for patients with Influenza

Dax : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Draguignan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Essey les Nancy : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Le Havre : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Limoges cedex : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Limoges cedex : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nantes cedex 2 : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza

Nantes cedex 2 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Nice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Orléans cedex 2 : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Poitiers Cedex : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Tours cedex 9 : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Germany

Berlin : PAREXEL Early Phase Clinical Unit

A clinical research study of Adjuvanted, trivalent subunit influenza vaccine, Adjuvant level modified adjuvanted, trivalent subunit influenza vaccine, Antigen level modified adjuvanted, trivalent subunit influenza vaccine and Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine for the treatment of Influenza

Berlin :

A Phase 4 clinical study for patients with Influenza

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Berlin : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Berlin : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Detmold : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Erlangen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Flensburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Frankfurt : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Goch : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Hamburg : 302, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Kehl : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Kleve-Materborn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Leipzig : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Loehne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Magdeburg : 301, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Muenchen : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Neumuenster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Radebeul : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Regensburg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Rostock : 304, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Schoenau am Koenigssee : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Stuttgart : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Trier : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Wuerzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Wurzen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Greece

Chaidari : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Goudi, Athens : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guatemala

Ciudad de Guatemala : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Ciudad de Guatemala : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guatemala City : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guatemala City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Guatemala City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Hong Kong

Kwun Tong : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Shatin :

A Phase 4 clinical study for patients with Influenza

Tuen Mun : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hungary

Balassagyarmat :

A clinical trial seeking patients for a research study for the treatment of Influenza

Budapest :

A clinical trial seeking patients for a research study for the treatment of Influenza

Budapest : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Csongrad :

A clinical trial seeking patients for a research study for the treatment of Influenza

Debrecen :

A clinical trial seeking patients for a research study for the treatment of Influenza

Debrecen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Gödöllő :

A clinical trial seeking patients for a research study for the treatment of Influenza

Gyor : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Gyula :

A clinical trial seeking patients for a research study for the treatment of Influenza

Gyula : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Kaposvár : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nyiregyhaza :

A clinical trial seeking patients for a research study for the treatment of Influenza

Szekesfehervar : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Székesfehérvár : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Szolnok : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Zalaegerszeg :

A clinical trial seeking patients for a research study for the treatment of Influenza

India

Civil Lines : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Lucknow : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Lucknow : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Pune : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Trivandrum : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Israel

Haifa : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Jerusalem : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Jerusalem : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Petach Tikva : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Petach Tikva : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Ramat-Gan : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tel Aviv : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tel Hashomer : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Italy

Aviano : 007, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Brescia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Chieti : 005, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Florence : 030, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Genova : 023, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Milan : 002, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Milan : 001, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Milano : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Monza : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Monza : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Napoli : 025, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Novara : 021, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Parma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Parma : 004, Novartis Investigational Site

Patients are needed to participate in a clinical research study of Novartis Investigational H5N1 vaccine and Novartis Seasonal Influenza Vaccine

Pavia : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pisa : 024, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Roma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Roma : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Roma : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Japan

Sumida-ku :

Patients are needed to participate in a clinical research study of TAK-850 to evaluate Influenza

Yamanashi : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Kenya

Kisumu : KEMRI/CDC- IEIP surveillance-Asembo

A clinical trial seeking patients for a research study for the treatment of Influenza, Influenza Like Illness or Severe Acute Respiratory Illness

Nairobi : KEMRI/CDC IEIP surveillance- Kibera

A clinical trial seeking patients for a research study for the treatment of Influenza, Influenza Like Illness or Severe Acute Respiratory Illness

Korea, Republic of

Daejeon : 17 Ju Saengmyeong internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Daejeon : 18 Ju Saengmyeong internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Daejeon : 16 Daejeon hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Gimpo : 29 KeeTaek Kim internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Gyeonggi : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Incheon : 25 SeoIncheon catholic clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Incheon : 26 SeokYeon Kim internal medicine clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Incheon : 24 TaeIl Jang internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Jeongeup : 28 Jiguchon internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Kangwon-do : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Mokpo : 10 21th Century hana internal medicine clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Seoul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Seoul : 30 Yeonsei Koum internal medicine Clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 14 Global care internal medicine clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 32 Seoul medical center

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 04 Soon Chun Hyang University Hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 13 Lee internal medicine clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 33 Seoul National University Hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 31 Soon Chun Hyang University Hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 05 Yonsei University Severance Hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 12 Gikim internal medicine clinic

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Seoul : 06 Kangnam Sacred Heart Hospital

Patients are needed to participate in a clinical research study of Novartis MF59-adjuvanted influenza subunit vaccine and Sandoz Korea MF59-adjuvanted influenza subunit vaccine to evaluate Influenza (Seasonal)

Latvia

Riga : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Lithuania

Kaunas : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Klaipeda : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Siauliai : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Vilnius : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico

Acapulco : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Chihuahua : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Colonia Chamilpa, Cuernavaca : 03, Centro Médico Universitario

A clinical trial to evaluate treatments using Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29) and Non-adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29). for patients with Influenza

Cuautitlan Izcalli : Phylasis Clinicas Research S de RL de CV

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Cuautitlan Izcalli : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Cuernavaca : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Culiacán : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Durango : Nucleo Victoria de Investigacion Clinica S.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Guadalajara : Centro de Investigacion Medico Biologica y Terapia Avanzada (CIMBYTA)

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Guadalajara : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Guadalajara : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Guadalajara : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Guadalajara : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Jalapa Enriquez : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Mexico : Centro de Investigacion Clinica Acelerada, S.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mexico : Hospital Angeles Lindavista

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mexico : Facultad Mexicana de Medicina, Universidad La Salle A.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mexico : Mexico Centre for Clinical Research S.A. de C.V

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mexico : Centro de Investigacion Clinica GRAMEL S.C

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Mexico : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Mexico City : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Mexico, Distrito Federal : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Monterrey : Centro de Investigaction y Transferencia en Salud del Tecnologico de Monterrey

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Monterrey : Hospital Universitario de Monterrey

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Monterrey : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Monterrey : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Oaxaca : Oaxaca Site Management Organization S.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Tlalnepantla : Clinical Research Institute S.C.

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Zapopan : Hospital de Especialidades Centro Medico Puerta de Hierro

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Zapopan : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Netherlands

Hoogvliet :

A clinical trial seeking patients for a research study for the treatment of Influenza

Lieshout :

A clinical trial seeking patients for a research study for the treatment of Influenza

Nijmegen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Nijverdal :

A clinical trial seeking patients for a research study for the treatment of Influenza

Nijverdal :

A clinical trial seeking patients for a research study for the treatment of Influenza

Rotterdam :

A clinical trial seeking patients for a research study for the treatment of Influenza

Zwijndrecht :

A clinical trial seeking patients for a research study for the treatment of Influenza

New Zealand

Auckland :

A clinical trial seeking patients for a research study for the treatment of Influenza

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Auckland : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Christchurch :

A clinical trial seeking patients for a research study for the treatment of Influenza

Christchurch : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Hamilton :

A clinical trial seeking patients for a research study for the treatment of Influenza

Hastings : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Newtown : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Tauranga :

A clinical trial seeking patients for a research study for the treatment of Influenza

Norway

Bergen : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Trondheim : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Peru

Arequipa : Hospital Nacional Carlos Alberto Seguin Escobedo

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Arequipa : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Cusco : Hospital Nacional Adolfo Guevara Velasco

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Cusco : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Ica : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lima : Clinica Internacional Sede San Borja

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Lima : Clinica San Borja

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Lima : Hospital Nacional Arzobispo Loayza

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Lima : Hospital Maria Auxiliadora

A clinical trial to evaluate treatments using 40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate and Placebo for patients with Influenza

Lima : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lima : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lima : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lima : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Lima : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Loreto : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Miraflores : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Piura : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Trujillo : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Poland

Bialystok : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Bydgoszcz : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Debica :

A clinical trial seeking patients for a research study for the treatment of Influenza

Debica : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Debica : 040, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Debica : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Gdansk : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Katowice :

A clinical trial seeking patients for a research study for the treatment of Influenza

Katowice :

A clinical trial seeking patients for a research study for the treatment of Influenza

Katowice :

A clinical trial seeking patients for a research study for the treatment of Influenza

Katowice :

A clinical trial seeking patients for a research study for the treatment of Influenza

Katowice : 042, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Katowice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Krakow :

A Phase 4 clinical study for patients with Influenza

Kraków :

A clinical trial seeking patients for a research study for the treatment of Influenza

Leczna : 052, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lodz :

A clinical trial seeking patients for a research study for the treatment of Influenza

Lodz : 048, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Lodz : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Lódz :

A clinical trial seeking patients for a research study for the treatment of Influenza

Losice :

A clinical trial seeking patients for a research study for the treatment of Influenza

Lubartow : 049, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Oborniki Slaskie : 051, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Olesnica :

A clinical trial seeking patients for a research study for the treatment of Influenza

Olsztyn : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Osielsko : 046, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Ostroda :

A clinical trial seeking patients for a research study for the treatment of Influenza

Oswiecim :

A clinical trial seeking patients for a research study for the treatment of Influenza

Poznan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Rzeszow :

A clinical trial seeking patients for a research study for the treatment of Influenza

Siemianowice Slaskie : 043, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Siemianowice Slaskie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Swidnik :

A clinical trial seeking patients for a research study for the treatment of Influenza

Szczecin : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Szczecin : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Tarnow : 047, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Tarnów :

A clinical trial seeking patients for a research study for the treatment of Influenza

Torun :

A clinical trial seeking patients for a research study for the treatment of Influenza

Warszawa : 041, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Warszawa : 050, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Wola : 045, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Wroclaw :

A clinical trial seeking patients for a research study for the treatment of Influenza

Wroclaw :

A clinical trial seeking patients for a research study for the treatment of Influenza

Wroclaw : 044, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Wroclaw : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Zabrze : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Zgierz :

A clinical trial seeking patients for a research study for the treatment of Influenza

Puerto Rico

Manati : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Juan : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

San Juan : Updated

Patients are needed to participate in a clinical research study of favipiravir to evaluate Influenza

Russian Federation

Arkangelsk :

A clinical trial seeking patients for a research study for the treatment of Influenza

Barnaul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Barnaul : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Kazan :

A clinical trial seeking patients for a research study for the treatment of Influenza

Moscow :

A clinical trial seeking patients for a research study for the treatment of Influenza

Novosibirsk :

A clinical trial seeking patients for a research study for the treatment of Influenza

Ryazan :

A clinical trial seeking patients for a research study for the treatment of Influenza

Saint-Petersburg : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Saratov :

A clinical trial seeking patients for a research study for the treatment of Influenza

Saratov :

Patients are needed to participate in a clinical research study evaluating Arbidol (Umifenovir) and placebo for the treatment of Influenza

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Vladimir :

A clinical trial seeking patients for a research study for the treatment of Influenza

Yaroslavl :

A clinical trial seeking patients for a research study for the treatment of Influenza

Slovakia

Bratislava : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

South Africa

Amanzimtoti :

A clinical trial seeking patients for a research study for the treatment of Influenza

Bloemfontein :

A clinical trial seeking patients for a research study for the treatment of Influenza

Bloemfontein : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Cape Town :

A clinical trial seeking patients for a research study for the treatment of Influenza

Cape Town :

A clinical trial seeking patients for a research study for the treatment of Influenza

Cape Town :

A clinical trial seeking patients for a research study for the treatment of Influenza

Cape Town :

A clinical trial seeking patients for a research study for the treatment of Influenza

Cape Town : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Dundee :

A clinical trial seeking patients for a research study for the treatment of Influenza

Durban :

A clinical trial seeking patients for a research study for the treatment of Influenza

Durban : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Johannesburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Johannesburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Johannesburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Johannesburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Johannesburg : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Krugersdorp :

A clinical trial seeking patients for a research study for the treatment of Influenza

Middelburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Middelburg : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Paarl :

A clinical trial seeking patients for a research study for the treatment of Influenza

Paarl : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Port Elizabeth : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Potchefstroom :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria :

A clinical trial seeking patients for a research study for the treatment of Influenza

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Sophiatown, Johannesburg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Soweto :

A clinical trial seeking patients for a research study for the treatment of Influenza

Soweto : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Tygerberg; Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Umkomaas :

A clinical trial seeking patients for a research study for the treatment of Influenza

Welkom :

A clinical trial seeking patients for a research study for the treatment of Influenza

Welkom : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Witbank :

A clinical trial seeking patients for a research study for the treatment of Influenza

Worcester :

A clinical trial seeking patients for a research study for the treatment of Influenza

Spain

Alicante : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Antequera/Málaga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Badalona : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Badalona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Barcelona : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Barcelona : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Burgos : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Granada : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Granada : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

L'Hospitalet de Llobregat : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Influenza, Human

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study evaluating oseltamivir and Alternative Control for the treatment of Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Madrid : Updated

Patients are needed to participate in a clinical research study of oseltamivir [Tamiflu] to evaluate Influenza

Murcia : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Pama de Mallorca : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Santiago de Compostela : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Sevilla : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating FLU-D-QIV IP and FLU-D-QIV LP for the treatment of Influenza

Sweden

Göteborg :

A clinical trial seeking patients for a research study for the treatment of Influenza

Karlskrona :

A clinical trial seeking patients for a research study for the treatment of Influenza

Linköping :

A clinical trial seeking patients for a research study for the treatment of Influenza

Malmö :

A clinical trial seeking patients for a research study for the treatment of Influenza

Stockholm :

A clinical trial seeking patients for a research study for the treatment of Influenza

Stockholm :

A clinical trial seeking patients for a research study for the treatment of Influenza

Taiwan

Banciao : 343, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taichung : 345, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taichung : 344, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Tainan : National Cheng Kung University Hospital

Patients are needed to participate in a clinical research study evaluating Pandemic Influenza Vaccine (H5N1) for the treatment of Pandemic Influenza

Taipei : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Taipei : National Taiwan University Hospital

Patients are needed to participate in a clinical research study evaluating AdimFlu-V for the treatment of Influenza

Taipei City : 340, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taipei City : 341, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taoyuan : 342, Novartis Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) and Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV) for the treatment of Influenza Virus

Taoyuan County : Chang Gung Memorial Hospital at Linkuo

Patients are needed to participate in a clinical research study evaluating AdimFlu-V for the treatment of Influenza

Turkey

Ankara :

A clinical trial seeking patients for a research study for the treatment of Influenza

Diyarbakir :

A clinical trial seeking patients for a research study for the treatment of Influenza

Duzce :

A clinical trial seeking patients for a research study for the treatment of Influenza

Erzurum :

A clinical trial seeking patients for a research study for the treatment of Influenza

Eskisehir :

A clinical trial seeking patients for a research study for the treatment of Influenza

Izmir :

A clinical trial seeking patients for a research study for the treatment of Influenza

Izmir :

A clinical trial seeking patients for a research study for the treatment of Influenza

Konya :

A clinical trial seeking patients for a research study for the treatment of Influenza

Samsun :

A clinical trial seeking patients for a research study for the treatment of Influenza

Trabzon :

A clinical trial seeking patients for a research study for the treatment of Influenza

United Kingdom

Cardiff : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

London :

A clinical trial seeking patients for a research study for the treatment of Influenza

Manchester : GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human